Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
368.2 USD | -4.55% | -2.42% | +4.56% |
Apr. 25 | Health Care Drops Amid Mixed Earnings -- Health Care Roundup | DJ |
Apr. 25 | West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised | MT |
Chart calendar West Pharmaceutical Services, Inc.
Upcoming events on West Pharmaceutical Services, Inc.
Past events on West Pharmaceutical Services, Inc.
2024-04-25 09:00 am | Q1 2024 Earnings Call |
2024-04-25 06:00 am | Q1 2024 Earnings Release |
2024-04-23 09:30 am | Annual General Meeting |
2024-04-22 | Ex-dividend day |
2024-03-19 09:00 am | KeyBanc Life Sciences & MedTech Forum |
2024-03-12 01:05 pm | Barclays Global Healthcare Conference |
2024-02-15 09:00 am | Q4 2023 Earnings Call |
2024-02-15 06:00 am | Q4 2023 Earnings Release |
2024-01-29 | Ex-dividend day |
2023-11-16 09:00 am | Stephens Investment Conference |
2023-11-14 05:00 am | Jefferies London Healthcare Conference |
2023-11-06 | Ex-dividend day |
2023-10-26 09:00 am | Q3 2023 Earnings Call |
2023-10-26 06:00 am | Q3 2023 Earnings Release |
2023-10-24 10:30 am | CPhI Worldwide Conference |
2023-10-16 | PDA Universe of Prefilled Syringes and Injection Devices Conference |
2023-09-14 05:50 am | Bank of America Global Healthcare Conference |
2023-08-16 06:00 pm | UBS Genomics 2.0 and MedTech Innovations Summit |
2023-07-27 09:00 am | Q2 2023 Earnings Call |
2023-07-27 06:00 am | Q2 2023 Earnings Release |
Past dividends on West Pharmaceutical Services, Inc.
2024-04-22 | Quarterly 0.2 USD |
2024-01-29 | Quarterly 0.2 USD |
2023-11-06 | Quarterly 0.2 USD |
2023-07-24 | Quarterly 0.19 USD |
2023-04-24 | Quarterly 0.19 USD |
2023-01-23 | Quarterly 0.19 USD |
2022-11-07 | Quarterly 0.19 USD |
2022-07-18 | Quarterly 0.18 USD |
2022-04-18 | Quarterly 0.18 USD |
2022-01-17 | Quarterly 0.18 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 840 1 821 1.05% | 2 147 2 114 1.57% | 2 832 2 821 0.37% | 2 887 2 855 1.12% | 2 950 2 958 -0.28% | 3 012 |
EBITDA Million USD | Released Forecast Spread | 400 402 -0.43% | 526 523 0.55% | 885 878 0.72% | 883 851 3.69% | 828 833 -0.62% | 836 |
EBIT Million USD | Released Forecast Spread | 296 293 1.07% | 417 409 2% | 762 755 0.96% | 762 732 4.11% | 691 692 -0.24% | 672 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 292 285 2.28% | 401 403 -0.39% | 749 747 0.22% | 680 727 -6.52% | 698 696 0.27% | 672 |
Net income Million USD | Released Forecast Spread | 242 231 4.84% | 346 340 1.88% | 662 659 0.46% | 586 612 -4.34% | 593 588 0.88% | 568 |
EPS USD | Released Forecast Spread | 3,21 3,05 5.36% | 4,57 4,52 1.2% | 8,67 8,64 0.3% | 7,73 8,22 -5.91% | 7,88 7,85 0.4% | 7,59 |
Announcement Date | 13/02/20 | 18/02/21 | 17/02/22 | 16/02/23 | 15/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 720 721 -0.13% | 771 754 2.26% | 687 727 -5.57% | 709 657 7.84% | 717 697 2.77% | 754 754 -0.05% | 747 750 -0.38% | 732 740 -1.02% | 695 672 3.53% | 743 | 785 | 799 | 750 | 836 |
EBITDA Million USD | Released Forecast Spread | 220 233 -5.9% | 257 241 6.65% | 216 235 -8.11% | 190 159 19.35% | 197 189 3.95% | 216 212 1.55% | 217 206 5.28% | 196 199 -1.74% | 159 148 6.88% | 192 | 231 | 249 | 198 | 265 |
EBIT Million USD | Released Forecast Spread | 190 201 -5.32% | 227 210 8.14% | 186 201 -7.35% | 159 129 23.27% | 165 157 5.34% | 185 178 3.85% | 181 171 5.76% | 160 163 -1.78% | 123 111 10.36% | 151 | 194 | 210 | 157 | 223 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 188 196 -4.02% | 227 211 7.82% | 136 200 -31.93% | 129 126 1.77% | 158 156 0.91% | 185 174 6.03% | 187 173 8.12% | 168 167 1.01% | 127 116 10.29% | 148 | 189 | 213 | 159 | 225 |
Net income Million USD | Released Forecast Spread | 174 160 8.65% | 189 170 11.15% | 121 161 -24.97% | 103 103 0.19% | 140 128 9.63% | 155 143 8.1% | 161 140 14.84% | 137 133 2.9% | 115 95,5 20.7% | 138 | 156 | 166 | 152 | 185 |
EPS USD | Released Forecast Spread | 2,29 2,10 9.26% | 2,48 2,23 11.41% | 1,59 2,12 -24.94% | 1,36 1,36 -0.15% | 1,85 1,69 9.74% | 2,06 1,90 8.64% | 2,14 1,86 15.36% | 1,83 1,76 3.75% | 1,55 1,26 22.58% | 1,83 | 2,09 | 2,28 | 1,71 | 2,40 |
Announcement Date | 28/04/22 | 28/07/22 | 27/10/22 | 16/02/23 | 27/04/23 | 27/07/23 | 26/10/23 | 15/02/24 | 25/04/24 | - | - | - | - | - |
Past sector events for West Pharmaceutical Services, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- WST Stock
- Calendar West Pharmaceutical Services, Inc.